BVNRY Stock Price, Chart, Stats & News

Bavarian Nordic A/S
Save
Bavarian Nordic A/S (BVNRY) does not currently pay a dividend.
2.21B
Market cap
12.56x
Current P/E
4.97x
Forward P/E
BVNRY chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Bavarian Nordic A/S is a Danish biopharmaceutical company specializing in the development, production, and global commercialization of essential, life-saving vaccines. Its marketed portfolio includes non-replicating vaccines for smallpox and monkeypox (known as IMVAMUNE, IMVANEX, and JYNNEOS), as well as human rabies protection (Rabipur/RabAvert), a tick-borne encephalitis vaccine (Encepur), and an Ebola vaccine (MVABEA). The company also boasts a robust pipeline of investigational therapies.
Similar securities
Based on sector and market capitalization
Report issue





